US Revenue

Pharma News

Gland Pharma US revenue: Proven growth with 42% rise

Finn November 7, 2026

Gland Pharma US revenue has experienced significant growth, rising 42% following four successful product launches. This remarkable increase highlights the...

Gland Pharma US revenue: Proven growth with 42% rise

Gland Pharma US revenue: Proven growth with 42% rise

FDA Approval Dialysis Drug: Proven Benefits for Patients

Generic Ketamine Injection: Proven FDA Approval for NRx

Embassy Columbia Pacific acquisition: Smart move worth ₹32.65 crore

Ethiopian pharmaceutical plant sale: Kilitch Drugs’ $14M deal

When can Bitcoin roulette live insights give players an edge?

Future-Proof Jobs: What Are the Best Options for You?

Generic Asthma Inhaler Approval: A Proven Win for Aurobindo

IV fluids price fixation: The Clear Path to Fair Pricing

Karnataka medicine price hike: The clear impact on hospital bills

Gland Pharma US revenue: Proven growth with 42% rise

FDA Approval Dialysis Drug: Proven Benefits for Patients

Generic Ketamine Injection: Proven FDA Approval for NRx

Embassy Columbia Pacific acquisition: Smart move worth ₹32.65 crore

Ethiopian pharmaceutical plant sale: Kilitch Drugs’ $14M deal

Gland Pharma US revenue: Proven growth with 42% rise

FDA Approval Dialysis Drug: Proven Benefits for Patients

Generic Ketamine Injection: Proven FDA Approval for NRx

Embassy Columbia Pacific acquisition: Smart move worth ₹32.65 crore

Ethiopian pharmaceutical plant sale: Kilitch Drugs’ $14M deal

Latest Post

Calendar

You may have missed

Latest Post

Tags

Calendar